Integra Lifesciences Holdings (IART) Return on Capital Employed Growth (1y) (2011 - 2026)
Integra Lifesciences Holdings (IART) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 125.00 |
| 10 | Integra Lifesciences Holdings | 1.52 Bn | 1.26 Bn | 216.98 Mn | -1,467.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,467.00 |
| Dec 31, 2025 | -1,648.00 |
| Sep 30, 2025 | -1,551.00 |
| Jun 30, 2025 | -1,878.00 |
| Mar 31, 2025 | -189.00 |
| Dec 31, 2024 | -232.00 |
| Sep 30, 2024 | -330.00 |
| Jun 30, 2024 | -368.00 |
| Mar 31, 2024 | -430.00 |
| Dec 31, 2023 | -354.00 |
| Sep 30, 2023 | -239.00 |
| Jun 30, 2023 | -109.00 |
| Mar 31, 2023 | 25.00 |
| Dec 31, 2022 | 104.00 |
| Sep 30, 2022 | 98.00 |
| Jun 30, 2022 | 80.00 |
| Mar 31, 2022 | 149.00 |
| Dec 31, 2021 | 91.00 |
| Sep 30, 2021 | 136.00 |
| Jun 30, 2021 | 389.00 |